9
with the narrowest diameter of 15.7 Å at Gln9 (Fig. 3B) . Previous optical and 1 electrophysiological analyses of the permeation of fluorescence dyes and ions with 2 different sizes suggested that HsCALHM1 has a large pore greater than 14 Å (10), which 3 is consistent with the diameter at the narrowest neck of OlCALHM1EM, allowing the 4 permeation of all hydrated ions and ATP (~7 Å). HsCALHM1 is both cation and anion 5 permeable at PNa: PK: PCa: PCl = 1: 1.14: 13.8: 0.52 (8), (10). The pore-facing residues in 6 the NTH are neutral (Gln9, Gln12, and Ser13), accounting for the weak charge selectivity. 7
Taken together, the pore architecture in the OLCALHM1EM structure is in excellent 8 agreement with the previous functional analysis of HsCALHM1. 9 To elucidate the functional role of the NTH, we truncated the NTH of OlCALHM1 10 (ΔN11 and ΔN19) ( Fig. 3C ) and measured the ATP release activity by a cell-based assay. 11
In the Ca 2+ -free open state, the ATP release activities of the NTH-truncated mutant 12 channels were markedly enhanced as compared to the wild-type, indicating that the NTH 13 importantly functions in the ATP release ( Fig. 3D ). However, in the Ca 2+ -bound closed 14 state, the NTH-truncated mutants showed little ATP release activities (Fig. 3E ). These 15 observations indicate that the NTH observed in our CALHM1 structure is indeed involved 16 in the channel conduction of ATP; however, the other structural components are 17 associated with the Ca 2+ -dependent channel closing. 18
19
Structures of HsCALHM2 and CeCLHM-1 and structural differences 20 among CALHM homologs 21 Next, we investigated the functional and structural diversity of the CALHM 22 family. Although various members of the CALHM family have been identified (11), (14), 23 (15), their ATP conductance activities remain elusive. Thus, we measured the ATP 24 release activities of HsCALHM2 and CeCLHM-1 by a cell-based assay. HsCALHM2-1 and CeCLHM-1-transfected HeLa cells exhibited greater RuR-sensitive increases in the 2 extracellular ATP concentration in response to lowering [Ca 2+ ]o compared to mock-3 transfected cells, indicating that HsCALHM2 and CeCLHM-1 form ATP-release 4 channels activated by low [Ca 2+ ]o, as in the CALHM1 channels ( Fig. S2A, B) . To further 5 understand the ATP conduction mechanisms of the CALHM family members, we 6 performed the cryo-EM analysis of HsCALHM2 and CeCLHM-1. HsCALHM2 and 7
CeCLHM-1 were purified without Ca 2+ and exchanged into the amphipol PMAL-C8. The 8 cryo-EM images were acquired on a Titan Krios electron microscope equipped with a 9
Falcon 3 direct electron detector. The 2D class averages of HsCALHM2 and CeCLHM-10 1 showed the top views of 11-mer and 9-mer, respectively. We finally reconstructed the 11 EM density maps of HsCALHM2 and CeCLHM-1 at resolutions of 3.51 Å and 3.6 Å, 12 respectively, according to the gold-standard Fourier shell correlation (FSC) = 0.143 13 criteria (Figs. S5, S6 and Table S1 ). 14 Unlike the OlCALHM1 8-mer structure, HsCALHM2 and CeCLHM-1 form the 15 11-mer (approximate dimensions of 93 Å in height × 143 Å in intracellular width) and 16 the 9-mer (approximate dimensions of 93 Å in height ×126 Å in intracellular width), 17 respectively (Fig. 4A ). The 11-mer structure of HsCALHM2 is similar to that of the 18 recently reported structure in the open state (22) . Each subunit of the three homologs, 19
OlCALHM1, HsCALHM2, and CeCLHM-1, adopts almost similar architectures 20 composed of the transmembrane domain (TMD) and the C-terminal domain (CTD) (Fig. 21 4B, C) . At the TMD, both HsCALHM2 and CeCLHM-1 have the 4-TM helix topology, 22 in which the NTH and TM1 of HsCALHM2 and CeCLHM-1 are also expected to face 23 the pore, similar to OlCALHM1. However, the NTH and TM1 are not visualized in the 24 11 density maps of HsCALHM2 and CeCLHM-1, indicating the conformational flexibility 1 of these regions. At the extracellular regions, two disulfide bonds between extracellular 2 loops 1 (EL1) and 2 (EL2) are conserved among the three CALHM homologs (Fig. S7) . 3 EL2, between TM3 and TM4, forms short helices that are arranged differently in the three 4 structures. At the CTD, the three CALHM homologs adopt distinct architectures (Fig. 4B, 5 C) . In contrast to OlCALHM1, HsCALHM2 and CeCLHM-1 have a CTH and additional 6 helices, and their arrangements are different between the two homologs ( Fig. 4B , C): The 7 CTD of HsCALHM2 consists of a CTH (Arg215-Phe250), which turns toward the pore 8 at Phe251, and three short helices. The CTD of CeCLHM-1 consists of a CTH (Leu220-9
Arg254), which turns toward the membrane at Phe257, and at least one short helix. In 10 addition to these structural observations, the low sequence identities within the CTDs 11 among the three homologs (OlCALHM1 vs. HsCALHM2: 23%, OlCALHM1 vs. 12
CeCLHM-1: 32%) suggest the structural divergence of the CTD among the CALHM 13 family members. 14 Similar to OlCALHM1, both the TMD and CTD are involved in the subunit 15 interactions in HsCALHM2 and CeCLHM-1 ( Fig. 4D-F) . At the TMD, TM2 of one 16 subunit and TM4' of the neighboring subunit form extensive hydrophobic interactions 17 ( Fig. 4D, E) . Particularly, two Pro residues on TM2 and TM3, and two Trp residues on 18 TM3 and TM4' form van der Waals interactions, resulting in the tight contacts of the 19 three TM helices (TM2, TM3, and TM4'), which are conserved among the three CALHM 20 structures (Figs. 4D, E and S7) . Structural comparisons of the three CALHM homologs 21
show the different relative positions and orientations of TM2 relative to TM4' of the 22 neighboring subunits (Fig. 4D ). The subunit interfaces between TM2 and TM4' in 23
OlCALHM1 are formed by tighter hydrophobic interactions, relative to those in 24 HsCALHM2 and CeCLHM-1: The distances between the Cα atoms of the intracellular 1 ends in TM2 and TM4' in OlCALHM1, HsCALHM2, 17.9, 2 and 16.8 Å, respectively (Fig. 4D ). These subtle differences in the subunit interfaces at 3 the TMD are likely to be associated with the different oligomeric assemblies. At the CTD 4 in the three CALHM structures, the neighboring CTHs entangle together and form 5 stacking interactions between the conserved aromatic residues: Phe and His residues in 6 one subunit, a Phe residue in the adjacent subunit, and two Tyr residues from the adjacent 7 subunit on the opposite side (Figs. 4F and S7) . Taken together, the structural comparisons 8 among the three CALHM homologs reveal both structural conservation (TM topology) 9
and divergence (structures of CTD and oligomeric assembly). 10 11 Oligomeric assembly mechanism of CALHM channels
12
The three different oligomeric assembly structures of the CALHM homologs 13 probably arise from the slight variations in the inter-subunit interactions formed at the 14 TMD and CTD. To investigate whether the TMD or CTD defines the oligomeric 15 stoichiometry, we constructed a chimeric channel, consisting of the TMD from 16
OlCALHM1 and the CTD from HsCALHM2 (named 'OlCALHM1c'). The purified 17
OlCALHM1c was exchanged into amphipol PMAL-C8 and subjected to the cryo-EM 18 analysis. Without imposing any symmetry, the 3D classification provided cryo-EM maps 19 of two different oligomeric states, the 8-mer and the 9-mer, but no 11-mer structure was 20 obtained (Figs. 5A, S8). We finally determined the cryo-EM structures of the 8-mer and 21 the 9-mer, both at resolutions of 3.4 Å (Figs. 5A, B, S8 and Table S1 ). The dimensions of 22 the 8-mer and 9-mer structures of OlCALHM1c are consistent with the 8-mer and 9-mer 23 structures of OlCALHM1 and CeCLHM-1, respectively ( Fig. 5B ). Since the densities of 24 13 the CTDs are obscure in both the 8-mer and 9-mer EM maps ( Fig. 5A ), we did not model 1 the entire CTD of the 8-mer and the side chains at the CTD of the 9-mer ( Fig. 5B ). By 2 contrast, the EM density maps corresponding to the TMD are clearly resolved in both 3 structures, allowing the identification of the residues in the TMD (Fig. 5B ). The TMD 4 structures of the respective subunits are almost identical between the 8-mer and the 9-mer 5 (RMSD of 0.55 Å over 184 Cα atoms) ( Fig. 5C ). 6
The subunit interfaces at the TMD of OlCALHM1c are almost the same as those 7 of OlCALHM1EM, formed by hydrophobic interactions between TM2 of one subunit and 8 TM4' (Fig. 5D ). Consistently, the 8-mer structure can be well superimposed with 9
OlCALHM1EM, with the same TMD element. On the other hand, superimposition of the 10 8-mer and the 9-mer based on a subunit shows a 0.6 Å displacement of the Cα atoms of 11 Ile202 on the intracellular end of TM4' (Fig. 5D ). The substitution of the CTD probably 12 allowed this subtle difference of TM4' at the TMD subunit interfaces, resulting in the 9-13 mer assembly ( Fig. 5B, E) . These observations indicate that the assembly stoichiometry 14 is mainly defined by the subunit interactions at the TMD (e.g., the TMD of OlCALHM1 15 forms the 8-mer or the 9-mer). This notion suggests that the diverse oligomeric states in 16 CALHM channels are generally determined by the subunit interactions at the TMD. 17
Although the three CALHM homologs adopt similar TM topologies, the TMD of 18 OlCALHM1 has low sequence identities with those of HsCALHM2 (29%) and 19
CeCLHM-1 (23%). These sequence differences within the TMDs among the CALHM 20 family members are likely to be reflected in their diverse oligomeric assemblies and 21 eventually in the different diameters of the channel pore, which may be associated with 22 the different specificities of the released substrates at distinct expression sites (5), (11), 23 (14). 24 1 Discussion 2 In this study, we present the cryo-EM structures of three CALHM homologs and 3 the two oligomeric states of the chimeric construct, revealing the ATP conduction and 4 oligomeric assembly mechanisms. Notably, the present 2.66 Å-resolution OlCALHM1 5 structure allowed the accurate modeling of the NTH and TM1 (Fig. S4A ), which form the 6 pore architecture in the Ca 2+ -free open state (Fig. 3A, B ). The analysis of the ΔNTH 7 mutants indicates that the NTH is involved in the channel conduction of the ATP (Fig.  8 3D). Although the NTH and TM1 are disordered in our HsCALHM2 and CeCLHM-1 9 structures, the comparable arrangement of the TM helices among OlCALHM1, 10 HsCALHM2, and CeCLHM-1 suggests that the NTH would similarly constitute the 11 channel pores in the CALHM family members. The pore constriction by the NTH is also 12 observed in gap junction channels (16), (17), indicating that this is a conserved structural 13 feature of these oligomeric channels, despite the lack of sequence similarity among them. 14 The ΔNTH mutant showed almost no ATP-release activity upon Ca 2+ -binding, 15 similar to the wild-type ( Fig. 3E ), suggesting that other structural components are 16 associated with the channel gating in OlCALHM1 ( Fig. 6A, B ). In the OlALHM1EM 17 structure, TM1 protrudes towards the channel pore, as compared to the other TMs ( Fig.  18   1D) . Recently, the cryo-EM structures of HsCALHM2 were reported in the open and 19 inhibited states at 3.3 and 2.7 Å resolutions, respectively (22). These structures showed 20 channel pore closing by the swing motion of TM1 by about 60° towards the pore axis, 21 driven by the binding of the inhibitor RUR at the base of the TM segment. Therefore, 22 these structures suggest the large rearrangement of TM1 upon the channel gating (22). 23
Given the structural and sequence similarities between OlCALHM1 and HsCALHM2 24 15 (Figs. 4B, C and S7), TM1 may undergo a large structural movement and block the pore 1 upon Ca 2+ binding in OlCALHM1 (Fig. 6A, B ). 2
For the subunit assembly of CALHM family proteins, the interactions at the TMD 3 are mostly important for the oligomeric stoichiometry. The hydrophobic residues 4 involved in the subunit interactions between TM2-TM4' at the TMD are conserved in the 5 CALHM1 orthologs, except for Met187 and Phe194 ( Fig. S1A-C) , implying a similar 6 assembly number of HsCALHM1. In taste bud cells, CALHM1 and CALHM3 form a 7 functionally heteromeric channel with fast activation (12). HsCALHM1 and HsCALHM3 8 have sequence identities of 47% overall and 54% within the TMD (Fig. S9 ), which are 9 relatively higher as compared to the sequence identity between HsCALHM1 and 10 HsCALHM2 (30% over the full-length and 33% within the TMD). Moreover, the residues 11 that are probably involved in the subunit assembly are conserved in both HsCALHM1 12 and HsCALHM3, implying that they can form a heterooctamer, although the different 13 residues of the CTD could slightly modify this assembly. Overall, our current study 14 provides the ATP conduction and diverse assembly mechanisms of the CALHM family 15 Acknowledgements: We thank T. Nakane for assistance with the single-particle 12 analysis. We also thank the staff scientists at the University of Tokyo's cryo-EM facility, The DNAs encoding the Oryzias latipes CALHM1 channel (UniProt ID: 6 H2MCM1) and the Homo sapiens CALHM2 (UniProt ID: Q9HA72) were codon 7 optimized for eukaryotic expression systems, synthesized (Genewiz, Inc.), and served as 8 the templates for subcloning. To improve the expression and thermostability, the C-9 terminal residues starting from Trp296 were truncated (OlCALHM1EM). The chimeric 10 construct consists of the TMD in OlCALHM1 (Met1-Ala209) followed by the CTD in 11
HsCALHM2 (Ser213-Ser323). These DNA fragments were ligated into a modified pEG 12
BacMam vector, with a C-terminal green fluorescent protein (GFP)-His8 tag and a 13 tobacco etch virus (TEV) cleavage site, and were expressed in HEK293S GnTI − (N-14 acetylglucosaminyl-transferase I-negative) cells (American Type Culture Collection, 15 catalog no. CRL-3022) (24). Cells were collected by centrifugation (8,000 × g, 10 min, 16 4°C). For the cells expressing OlCALHM1c, the cells were disrupted by probe sonication 17 and the membrane fraction was collected by ultracentrifugation (186,000 × g, 1 h, 4°C). 18
The cells or the membrane fraction were solubilized for 1 h in buffer containing 50 mM 19
Tris, pH 8.0, 150 mM NaCl, 2 mM dithiothreitol (DTT), 1% DDM (Calbiochem), and 20 0.2% cholesterol hemisuccinate (CHS). The mixture was centrifuged at 40,000g for 20 21 min, and the supernatant was incubated with CNBr-Activated Sepharose 4 Fast Flow 22 beads (GE Healthcare) coupled with an anti-GFP nanobody (GFP enhancer or GFP 23 minimizer) (25) for 2 h at 4°C. The protein-bound resins were washed with gel filtration 24 25 buffer (50 mM Tris, pH 8.0, 150 mM NaCl, 2 mM dithiothreitol) containing 0.05% GDN 1 for OlCALHM1EM and OlCALHM1c or 0.06% digitonin for HsCALHM2, and further 2 incubated overnight with TEV protease. The flow through was concentrated using a 3 centrifugal filter unit (Merck Millipore, 100 kDa molecular weight cutoff), and separated 4 on a Superose 6 Increase 10/300 GL column (GE Healthcare) equilibrated with gel 5 filtration buffer. The peak fractions of the protein were pooled. were further incubated at 30°C in the presence of 8% CO2 for 48 h. The cells were 19 collected by centrifugation (3,000 × g, 10 min, 4°C) and disrupted by Dounce 20 homogenization in hypotonic buffer (50 mM HEPES-NaOH (pH 7.5), 10 mM KCl, 0.04 21 mg ml −1 DNase I, and protease inhibitor cocktail). The membrane fraction was collected 22 by ultracentrifugation (138,000 × g, 1 h, 4°C), and solubilized for 1 h at 4°C in buffer 23 (50 mM HEPES-NaOH (pH 7.5), 300 mM NaCl, 1.5% (w/v) N-dodecyl β-D-maltoside 24 26 (DDM), and 0.15% (w/v) cholesterol hemisuccinate (CHS)). After ultracentrifugation 1 (138,000 × g, 30 min, 4°C), the supernatant was incubated with AffiGel 10 (Bio-Rad) 2 coupled with a GFP-binding nanobody, for 2 h at 4°C. The resin was washed five times 3 with 3 CVs of wash buffer (50 mM HEPES-NaOH (pH 7.5), 300 mM NaCl, and 0.06% 4 glyco-diogenin (GDN)), and gently suspended overnight with TEV protease to cleave the 5 His8-EGFP tag. After the TEV protease digestion, the flow-through was pooled, 6 concentrated, and purified by size-exclusion chromatography on a Superose 6 Increase 7 10/300 GL column (GE Healthcare), equilibrated with SEC buffer (20 mM HEPES-8 NaOH (pH 7.5), 150 mM NaCl, and 0.06% GDN). The peak fractions of the protein were 9 pooled. 10 11 Grid preparation
The purified OlCALHM1EM protein in GDN was concentrated to 5 mg ml −1 . For 13 cryo-EM analyses of HsCALHM2, CeCLHM-1, and OlCALHM1c, the detergents were 14 exchanged with amphipols. The purified HsCALHM2 in digitonin, CeCLHM-1 in GDN, 15 and OlCALHM1c in GDN were mixed with amphipol PMAL-C8 (Anatrace) at a 1:100 16 ratio (w/w) for 2-2.5 h at 4°C. Detergents were removed using Bio-Beads SM-2 (Bio-17 Rad, 100 mg per 1 ml mixture) for 2-2.5 h at 4°C. After removal of the Bio-Beads, the 18 samples were concentrated and subjected to size-exclusion chromatography on a 19 Superose 6 Increase 10/300 GL column (GE Healthcare), equilibrated with buffer (20 20 mM Tris-HCl, pH 8.0, 150 mM NaCl, 2 mM dithiothreitol). The peak fractions containing 21
HsCALHM2, CeCLHM-1, and the OlCALHM1c in PMAL-C8 were concentrated to 1.6, 22 2.2, and 1 mg ml −1 , respectively. Portions (3 µl) of the concentrated samples were applied 23 to glow-discharged R1.2/1.3 Cu/Rh 300 mesh grids (Quantifoil). The grids were 24 27 subsequently blotted (4 s for OlCALHM1EM, 8 s for HsCALHM2, 4 s for CeCLHM-1, 1 and 4 s for OlCALHM1c) and vitrified using a Vitrobot Mark IV (FEI) under 4°C and 2 100% humidity conditions. 3 4 EM image acquisition and data processing 5 For OlCALHM1EM and OlCALHM1c, data collections were performed on an FEI 6 Titan Krios (FEI) electron microscope, operating at an acceleration voltage of 300 kV and 7 equipped with a BioQuantum K3 imaging filter and a K3 direct electron detector (Gatan). 8 EM images were acquired at a nominal magnification of 105,000 ×, corresponding to a 9 physical pixel size of 0.83 Å, using the SerialEM software (26). For OlCALHM1EM, 10 movies were dose fractionated to 54 frames at a dose rate of 14.9 e − pixel −1 per second, 11 resulting in a total accumulated dose of 59.4 e − Å −2 . For OlCALHM1c, movies were dose 12 fractionated to 48 frames at a dose rate of 14.0 e − pixel −1 per second, resulting in a total 13 accumulated dose of 50 e − Å −2 . For HsCALHM2 and CeCLHM-1, data collections were 14 performed on a 300 kV Titan Krios electron microscope equipped with a Falcon III direct 15 electron detector. EM images were acquired at a nominal magnification of 96,000 ×, 16 corresponding to a calibrated pixel size of 0.8346 Å pixel −1 , using the EPU software. For 17 HsCALHM2, movies were dose fractionated to 60 frames at a dose rate of 0.95 e − pixel −1 18 per second, resulting in a total accumulated dose of 60 e − Å −2 . For CeCLHM-1, movies 19 were dose fractionated to 48 frames at a dose rate of 0.7 e − pixel −1 per second, resulting 20 in a total accumulated dose of 50 e − Å −2 . For all datasets, the movie frames were aligned 21 in 4 × 4 patches and dose-weighted using RELION (27) . CTF estimation was performed 22 by CTFFIND 4.1 (28). 23
For the OlCALHM1EM dataset, a total of 1,231,992 particles were extracted from 24 added to each well and the plate was placed in a microplate luminometer (Centro LB960, 1 Berthold Technologies, Bad Wildbad, Germany). Luminescence was measured every 2 2 min at 25 ºC. The extracellular ATP concentration was calculated from a standard curve 3 created in each plate. The standard bath solution contained (in mM): 150 NaCl, 5 KCl, 2 4
CaCl2, 1 MgCl2, 10 HEPES, and 10 glucose, pH 7.4 adjusted with NaOH. The Ca 2+ -free 5 bath solution contained (in mM): 150 NaCl, 5 KCl, 5 EGTA, 1 MgCl2, 10 Hepes, and 10 6 glucose, pH 7.4 adjusted with NaOH. 7 8 Preparation of proteoliposomes 9 Lipids from chloroform stocks, mixed at a 2:1 weight ratio of 1-palmitoyl-2-10 oleoyl-sn-glycero-3-phosphoglycerol (Avanti) with 12% egg phosphatidylcholine:1-11 palmitoyl-2-oleoyl-sn-glycero-3-phosphoglycerol (Avanti), were dried and solubilized in 12 a solution containing 100 mM KCl, 0.1 mM EGTA, 2.3% n-octyl-β-D-glucopyranoside, 13 and 25 mM HEPES, pH 7.6. Solubilized OlCALHM1EM was added to the lipid-detergent 14 mixture at a 50:1 lipid to protein ratio. After a short incubation, Bio-Beads SM-2 (Bio-15 Rad) were added and mixed at 4°C overnight. To confirm the reconstitution, after 16 ultracentrifugation (125,000g, 15 min, 4°C) and solubilization in buffer (50 mM Tris-HCl, 17 pH 8.0, 150 mM NaCl, 1.0% DDM, and 0.2% CHS) at 4°C for 1 h, the proteoliposomal 18 solutions were subjected to SDS-PAGE. 19 20 ATP transport assay 21 Liposomes and proteoliposomes were loaded with 1 mM ATP and sonicated for 22 30 s, using a Bioruptor (CosmoBio). After removal of the extraliposomal ATP by 23 chromatography on Sephadex G-50 fine resin (GE Healthcare), 50 μl portions of the 24 samples were combined with 50 μl of a mixture containing 45 nM luciferase (QuantiLum 25 32 Photinus pyralis recombinant luciferase; Promega, Madison, WI), 1.2 nM luciferin 1 (Nacalai Tesque), 1.0 mM EDTA, and 10 mM MgSO4. After 1h incubation with or 2 without 0.4% Triton X-100, the luminescence was measured on an ARVO-X3 microplate 3 reader (PerkinElmer). The amount of ATP retained in the liposomes was determined as 4 the difference in the luminescence between total ATP and extraliposomal ATP that was 5 accessible to luciferase without Triton X-100. (low) to maroon (high). The residues constituting the subunit interface are indicated by 20 stick models. They are conserved in the CALHM1 orthologs, except for Met187 and 21
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